Recently, inhibitors for mammalian ELOVL6 were developed, and the compounds were tested in diet-induced obesity animals and KKAy mice, a genetically obese and diabetic animal model. This evidence concerns the gene ELOVL6 and obesity due to melanocortin 4 receptor deficiency.